Medical Devices & Consumables
Global Dry Powder Inhaler Device Market Research Report 2026
- Feb 24, 26
- ID: 719078
- Pages: 120
- Figures: 125
- Views: 1
This report delivers a comprehensive overview of the global Dry Powder Inhaler Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dry Powder Inhaler Device. The Dry Powder Inhaler Device market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dry Powder Inhaler Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dry Powder Inhaler Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Segment by Type
Single Dose
Multi Dose
by Application
Asthma
COPD
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Dry Powder Inhaler Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Dry Powder Inhaler Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Dry Powder Inhaler Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dry Powder Inhaler Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Segment by Type
Single Dose
Multi Dose
by Application
Asthma
COPD
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Dry Powder Inhaler Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Dry Powder Inhaler Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Dry Powder Inhaler Device Market Overview
1.1 Product Definition
1.2 Dry Powder Inhaler Device by Type
1.2.1 Global Dry Powder Inhaler Device Market Value by Type: 2025 vs 2032
1.2.2 Single Dose
1.2.3 Multi Dose
1.3 Dry Powder Inhaler Device by Application
1.3.1 Global Dry Powder Inhaler Device Market Value by Application: 2025 vs 2032
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts
1.4.1 Global Dry Powder Inhaler Device Revenue 2021–2032
1.4.2 Global Dry Powder Inhaler Device Sales 2021–2032
1.4.3 Global Dry Powder Inhaler Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dry Powder Inhaler Device Market Competition by Manufacturers
2.1 Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dry Powder Inhaler Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dry Powder Inhaler Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dry Powder Inhaler Device, Product Types and Applications
2.7 Global Key Manufacturers of Dry Powder Inhaler Device, Date of Entry into the Industry
2.8 Global Dry Powder Inhaler Device Market Competitive Situation and Trends
2.8.1 Global Dry Powder Inhaler Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dry Powder Inhaler Device Players Market Share by Revenue
2.8.3 Global Dry Powder Inhaler Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dry Powder Inhaler Device Market Scenario by Region
3.1 Global Dry Powder Inhaler Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dry Powder Inhaler Device Sales by Region: 2021–2032
3.2.1 Global Dry Powder Inhaler Device Sales by Region: 2021–2026
3.2.2 Global Dry Powder Inhaler Device Sales by Region: 2027–2032
3.3 Global Dry Powder Inhaler Device Revenue by Region: 2021–2032
3.3.1 Global Dry Powder Inhaler Device Revenue by Region: 2021–2026
3.3.2 Global Dry Powder Inhaler Device Revenue by Region: 2027–2032
3.4 North America Dry Powder Inhaler Device Market Facts & Figures by Country
3.4.1 North America Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dry Powder Inhaler Device Sales by Country (2021–2032)
3.4.3 North America Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dry Powder Inhaler Device Market Facts & Figures by Country
3.5.1 Europe Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dry Powder Inhaler Device Sales by Country (2021–2032)
3.5.3 Europe Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Powder Inhaler Device Market Facts & Figures by Region
3.6.1 Asia Pacific Dry Powder Inhaler Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dry Powder Inhaler Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Dry Powder Inhaler Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dry Powder Inhaler Device Market Facts & Figures by Country
3.7.1 Latin America Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dry Powder Inhaler Device Sales by Country (2021–2032)
3.7.3 Latin America Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Powder Inhaler Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dry Powder Inhaler Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dry Powder Inhaler Device Sales by Type (2021–2032)
4.1.1 Global Dry Powder Inhaler Device Sales by Type (2021–2026)
4.1.2 Global Dry Powder Inhaler Device Sales by Type (2027–2032)
4.1.3 Global Dry Powder Inhaler Device Sales Market Share by Type (2021–2032)
4.2 Global Dry Powder Inhaler Device Revenue by Type (2021–2032)
4.2.1 Global Dry Powder Inhaler Device Revenue by Type (2021–2026)
4.2.2 Global Dry Powder Inhaler Device Revenue by Type (2027–2032)
4.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Type (2021–2032)
4.3 Global Dry Powder Inhaler Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dry Powder Inhaler Device Sales by Application (2021–2032)
5.1.1 Global Dry Powder Inhaler Device Sales by Application (2021–2026)
5.1.2 Global Dry Powder Inhaler Device Sales by Application (2027–2032)
5.1.3 Global Dry Powder Inhaler Device Sales Market Share by Application (2021–2032)
5.2 Global Dry Powder Inhaler Device Revenue by Application (2021–2032)
5.2.1 Global Dry Powder Inhaler Device Revenue by Application (2021–2026)
5.2.2 Global Dry Powder Inhaler Device Revenue by Application (2027–2032)
5.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Application (2021–2032)
5.3 Global Dry Powder Inhaler Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Chiesi
6.4.1 Chiesi Company Information
6.4.2 Chiesi Description and Business Overview
6.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
6.4.5 Chiesi Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 3M
6.6.1 3M Company Information
6.6.2 3M Description and Business Overview
6.6.3 3M Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 3M Dry Powder Inhaler Device Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Hovione
6.7.1 Hovione Company Information
6.7.2 Hovione Description and Business Overview
6.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
6.7.5 Hovione Recent Developments/Updates
6.8 Mannkind
6.8.1 Mannkind Company Information
6.8.2 Mannkind Description and Business Overview
6.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
6.8.5 Mannkind Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Schering/Merck
6.11.1 Schering/Merck Company Information
6.11.2 Schering/Merck Description and Business Overview
6.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
6.11.5 Schering/Merck Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Teva Dry Powder Inhaler Device Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Vectura
6.13.1 Vectura Company Information
6.13.2 Vectura Description and Business Overview
6.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
6.13.5 Vectura Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Powder Inhaler Device Industry Chain Analysis
7.2 Dry Powder Inhaler Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Powder Inhaler Device Production Mode & Process Analysis
7.4 Dry Powder Inhaler Device Sales and Marketing
7.4.1 Dry Powder Inhaler Device Sales Channels
7.4.2 Dry Powder Inhaler Device Distributors
7.5 Dry Powder Inhaler Device Customer Analysis
8 Dry Powder Inhaler Device Market Dynamics
8.1 Dry Powder Inhaler Device Industry Trends
8.2 Dry Powder Inhaler Device Market Drivers
8.3 Dry Powder Inhaler Device Market Challenges
8.4 Dry Powder Inhaler Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Dry Powder Inhaler Device by Type
1.2.1 Global Dry Powder Inhaler Device Market Value by Type: 2025 vs 2032
1.2.2 Single Dose
1.2.3 Multi Dose
1.3 Dry Powder Inhaler Device by Application
1.3.1 Global Dry Powder Inhaler Device Market Value by Application: 2025 vs 2032
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts
1.4.1 Global Dry Powder Inhaler Device Revenue 2021–2032
1.4.2 Global Dry Powder Inhaler Device Sales 2021–2032
1.4.3 Global Dry Powder Inhaler Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dry Powder Inhaler Device Market Competition by Manufacturers
2.1 Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dry Powder Inhaler Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dry Powder Inhaler Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dry Powder Inhaler Device, Product Types and Applications
2.7 Global Key Manufacturers of Dry Powder Inhaler Device, Date of Entry into the Industry
2.8 Global Dry Powder Inhaler Device Market Competitive Situation and Trends
2.8.1 Global Dry Powder Inhaler Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dry Powder Inhaler Device Players Market Share by Revenue
2.8.3 Global Dry Powder Inhaler Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dry Powder Inhaler Device Market Scenario by Region
3.1 Global Dry Powder Inhaler Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dry Powder Inhaler Device Sales by Region: 2021–2032
3.2.1 Global Dry Powder Inhaler Device Sales by Region: 2021–2026
3.2.2 Global Dry Powder Inhaler Device Sales by Region: 2027–2032
3.3 Global Dry Powder Inhaler Device Revenue by Region: 2021–2032
3.3.1 Global Dry Powder Inhaler Device Revenue by Region: 2021–2026
3.3.2 Global Dry Powder Inhaler Device Revenue by Region: 2027–2032
3.4 North America Dry Powder Inhaler Device Market Facts & Figures by Country
3.4.1 North America Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dry Powder Inhaler Device Sales by Country (2021–2032)
3.4.3 North America Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dry Powder Inhaler Device Market Facts & Figures by Country
3.5.1 Europe Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dry Powder Inhaler Device Sales by Country (2021–2032)
3.5.3 Europe Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Powder Inhaler Device Market Facts & Figures by Region
3.6.1 Asia Pacific Dry Powder Inhaler Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dry Powder Inhaler Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Dry Powder Inhaler Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dry Powder Inhaler Device Market Facts & Figures by Country
3.7.1 Latin America Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dry Powder Inhaler Device Sales by Country (2021–2032)
3.7.3 Latin America Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Powder Inhaler Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dry Powder Inhaler Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dry Powder Inhaler Device Sales by Type (2021–2032)
4.1.1 Global Dry Powder Inhaler Device Sales by Type (2021–2026)
4.1.2 Global Dry Powder Inhaler Device Sales by Type (2027–2032)
4.1.3 Global Dry Powder Inhaler Device Sales Market Share by Type (2021–2032)
4.2 Global Dry Powder Inhaler Device Revenue by Type (2021–2032)
4.2.1 Global Dry Powder Inhaler Device Revenue by Type (2021–2026)
4.2.2 Global Dry Powder Inhaler Device Revenue by Type (2027–2032)
4.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Type (2021–2032)
4.3 Global Dry Powder Inhaler Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dry Powder Inhaler Device Sales by Application (2021–2032)
5.1.1 Global Dry Powder Inhaler Device Sales by Application (2021–2026)
5.1.2 Global Dry Powder Inhaler Device Sales by Application (2027–2032)
5.1.3 Global Dry Powder Inhaler Device Sales Market Share by Application (2021–2032)
5.2 Global Dry Powder Inhaler Device Revenue by Application (2021–2032)
5.2.1 Global Dry Powder Inhaler Device Revenue by Application (2021–2026)
5.2.2 Global Dry Powder Inhaler Device Revenue by Application (2027–2032)
5.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Application (2021–2032)
5.3 Global Dry Powder Inhaler Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Chiesi
6.4.1 Chiesi Company Information
6.4.2 Chiesi Description and Business Overview
6.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
6.4.5 Chiesi Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 3M
6.6.1 3M Company Information
6.6.2 3M Description and Business Overview
6.6.3 3M Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 3M Dry Powder Inhaler Device Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Hovione
6.7.1 Hovione Company Information
6.7.2 Hovione Description and Business Overview
6.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
6.7.5 Hovione Recent Developments/Updates
6.8 Mannkind
6.8.1 Mannkind Company Information
6.8.2 Mannkind Description and Business Overview
6.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
6.8.5 Mannkind Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Schering/Merck
6.11.1 Schering/Merck Company Information
6.11.2 Schering/Merck Description and Business Overview
6.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
6.11.5 Schering/Merck Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Teva Dry Powder Inhaler Device Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Vectura
6.13.1 Vectura Company Information
6.13.2 Vectura Description and Business Overview
6.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
6.13.5 Vectura Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Powder Inhaler Device Industry Chain Analysis
7.2 Dry Powder Inhaler Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Powder Inhaler Device Production Mode & Process Analysis
7.4 Dry Powder Inhaler Device Sales and Marketing
7.4.1 Dry Powder Inhaler Device Sales Channels
7.4.2 Dry Powder Inhaler Device Distributors
7.5 Dry Powder Inhaler Device Customer Analysis
8 Dry Powder Inhaler Device Market Dynamics
8.1 Dry Powder Inhaler Device Industry Trends
8.2 Dry Powder Inhaler Device Market Drivers
8.3 Dry Powder Inhaler Device Market Challenges
8.4 Dry Powder Inhaler Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Dry Powder Inhaler Device Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Dry Powder Inhaler Device Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Dry Powder Inhaler Device Market Competitive Situation by Manufacturers in 2025
Table 4. Global Dry Powder Inhaler Device Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Dry Powder Inhaler Device Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Dry Powder Inhaler Device Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Dry Powder Inhaler Device Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Dry Powder Inhaler Device, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Dry Powder Inhaler Device, Product Types and Applications
Table 12. Global Key Manufacturers of Dry Powder Inhaler Device, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dry Powder Inhaler Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dry Powder Inhaler Device Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Dry Powder Inhaler Device Sales by Region (K Units), 2021–2026
Table 18. Global Dry Powder Inhaler Device Sales Market Share by Region (2021–2026)
Table 19. Global Dry Powder Inhaler Device Sales by Region (K Units), 2027–2032
Table 20. Global Dry Powder Inhaler Device Sales Market Share by Region (2027–2032)
Table 21. Global Dry Powder Inhaler Device Revenue by Region (US$ Million), 2021–2026
Table 22. Global Dry Powder Inhaler Device Revenue Market Share by Region (2021–2026)
Table 23. Global Dry Powder Inhaler Device Revenue by Region (US$ Million), 2027–2032
Table 24. Global Dry Powder Inhaler Device Revenue Market Share by Region (2027–2032)
Table 25. North America Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
Table 27. North America Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
Table 28. North America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
Table 29. North America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
Table 32. Europe Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
Table 33. Europe Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Dry Powder Inhaler Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Dry Powder Inhaler Device Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Dry Powder Inhaler Device Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Dry Powder Inhaler Device Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Dry Powder Inhaler Device Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
Table 42. Latin America Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
Table 43. Latin America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
Table 50. Global Dry Powder Inhaler Device Sales (K Units) by Type (2021–2026)
Table 51. Global Dry Powder Inhaler Device Sales (K Units) by Type (2027–2032)
Table 52. Global Dry Powder Inhaler Device Sales Market Share by Type (2021–2026)
Table 53. Global Dry Powder Inhaler Device Sales Market Share by Type (2027–2032)
Table 54. Global Dry Powder Inhaler Device Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Dry Powder Inhaler Device Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Dry Powder Inhaler Device Revenue Market Share by Type (2021–2026)
Table 57. Global Dry Powder Inhaler Device Revenue Market Share by Type (2027–2032)
Table 58. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2021–2026)
Table 59. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2027–2032)
Table 60. Global Dry Powder Inhaler Device Sales (K Units) by Application (2021–2026)
Table 61. Global Dry Powder Inhaler Device Sales (K Units) by Application (2027–2032)
Table 62. Global Dry Powder Inhaler Device Sales Market Share by Application (2021–2026)
Table 63. Global Dry Powder Inhaler Device Sales Market Share by Application (2027–2032)
Table 64. Global Dry Powder Inhaler Device Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Dry Powder Inhaler Device Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Dry Powder Inhaler Device Revenue Market Share by Application (2021–2026)
Table 67. Global Dry Powder Inhaler Device Revenue Market Share by Application (2027–2032)
Table 68. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2021–2026)
Table 69. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2027–2032)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. GlaxoSmithKline Dry Powder Inhaler Device Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. AstraZeneca Dry Powder Inhaler Device Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Boehringer Ingelheim Dry Powder Inhaler Device Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Chiesi Company Information
Table 86. Chiesi Description and Business Overview
Table 87. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Chiesi Dry Powder Inhaler Device Product
Table 89. Chiesi Recent Developments/Updates
Table 90. Cipla Company Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Cipla Dry Powder Inhaler Device Product
Table 94. Cipla Recent Developments/Updates
Table 95. 3M Company Information
Table 96. 3M Description and Business Overview
Table 97. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. 3M Dry Powder Inhaler Device Product
Table 99. 3M Recent Developments/Updates
Table 100. Hovione Company Information
Table 101. Hovione Description and Business Overview
Table 102. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Hovione Dry Powder Inhaler Device Product
Table 104. Hovione Recent Developments/Updates
Table 105. Mannkind Company Information
Table 106. Mannkind Description and Business Overview
Table 107. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Mannkind Dry Powder Inhaler Device Product
Table 109. Mannkind Recent Developments/Updates
Table 110. Mylan Company Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Mylan Dry Powder Inhaler Device Product
Table 114. Mylan Recent Developments/Updates
Table 115. Novartis Company Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. Novartis Dry Powder Inhaler Device Product
Table 119. Novartis Recent Developments/Updates
Table 120. Schering/Merck Company Information
Table 121. Schering/Merck Description and Business Overview
Table 122. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. Schering/Merck Dry Powder Inhaler Device Product
Table 124. Schering/Merck Recent Developments/Updates
Table 125. Teva Company Information
Table 126. Teva Description and Business Overview
Table 127. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Teva Dry Powder Inhaler Device Product
Table 129. Teva Recent Developments/Updates
Table 130. Vectura Company Information
Table 131. Vectura Description and Business Overview
Table 132. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. Vectura Dry Powder Inhaler Device Product
Table 134. Vectura Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Dry Powder Inhaler Device Distributors List
Table 138. Dry Powder Inhaler Device Customers List
Table 139. Dry Powder Inhaler Device Market Trends
Table 140. Dry Powder Inhaler Device Market Drivers
Table 141. Dry Powder Inhaler Device Market Challenges
Table 142. Dry Powder Inhaler Device Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dry Powder Inhaler Device
Figure 2. Global Dry Powder Inhaler Device Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Dry Powder Inhaler Device Market Share by Type: 2025 & 2032
Figure 4. Single Dose Product Picture
Figure 5. Multi Dose Product Picture
Figure 6. Global Dry Powder Inhaler Device Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Dry Powder Inhaler Device Market Share by Application: 2025 & 2032
Figure 8. Asthma
Figure 9. COPD
Figure 10. Others
Figure 11. Global Dry Powder Inhaler Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Dry Powder Inhaler Device Market Size (US$ Million), 2021–2032
Figure 13. Global Dry Powder Inhaler Device Sales (K Units), 2021–2032
Figure 14. Global Dry Powder Inhaler Device Average Price (USD/Unit), 2021–2032
Figure 15. Dry Powder Inhaler Device Report Years Considered
Figure 16. Dry Powder Inhaler Device Sales Share by Manufacturers in 2025
Figure 17. Global Dry Powder Inhaler Device Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Dry Powder Inhaler Device Players: Market Share by Revenue in Dry Powder Inhaler Device in 2025
Figure 19. Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
Figure 22. North America Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
Figure 23. U.S. Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
Figure 26. Europe Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
Figure 27. Germany Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Dry Powder Inhaler Device Revenue Market Share by Region (2021–2032)
Figure 34. China Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Taiwan Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Philippines Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
Figure 45. Latin America Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. U.A.E Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Dry Powder Inhaler Device by Type (2021–2032)
Figure 55. Global Revenue Market Share of Dry Powder Inhaler Device by Type (2021–2032)
Figure 56. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Dry Powder Inhaler Device by Application (2021–2032)
Figure 58. Global Revenue Market Share of Dry Powder Inhaler Device by Application (2021–2032)
Figure 59. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2021–2032)
Figure 60. Dry Powder Inhaler Device Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Dry Powder Inhaler Device Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Dry Powder Inhaler Device Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Dry Powder Inhaler Device Market Competitive Situation by Manufacturers in 2025
Table 4. Global Dry Powder Inhaler Device Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Dry Powder Inhaler Device Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Dry Powder Inhaler Device Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Dry Powder Inhaler Device Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Dry Powder Inhaler Device, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Dry Powder Inhaler Device, Product Types and Applications
Table 12. Global Key Manufacturers of Dry Powder Inhaler Device, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dry Powder Inhaler Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dry Powder Inhaler Device Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Dry Powder Inhaler Device Sales by Region (K Units), 2021–2026
Table 18. Global Dry Powder Inhaler Device Sales Market Share by Region (2021–2026)
Table 19. Global Dry Powder Inhaler Device Sales by Region (K Units), 2027–2032
Table 20. Global Dry Powder Inhaler Device Sales Market Share by Region (2027–2032)
Table 21. Global Dry Powder Inhaler Device Revenue by Region (US$ Million), 2021–2026
Table 22. Global Dry Powder Inhaler Device Revenue Market Share by Region (2021–2026)
Table 23. Global Dry Powder Inhaler Device Revenue by Region (US$ Million), 2027–2032
Table 24. Global Dry Powder Inhaler Device Revenue Market Share by Region (2027–2032)
Table 25. North America Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
Table 27. North America Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
Table 28. North America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
Table 29. North America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
Table 32. Europe Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
Table 33. Europe Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Dry Powder Inhaler Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Dry Powder Inhaler Device Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Dry Powder Inhaler Device Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Dry Powder Inhaler Device Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Dry Powder Inhaler Device Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
Table 42. Latin America Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
Table 43. Latin America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
Table 50. Global Dry Powder Inhaler Device Sales (K Units) by Type (2021–2026)
Table 51. Global Dry Powder Inhaler Device Sales (K Units) by Type (2027–2032)
Table 52. Global Dry Powder Inhaler Device Sales Market Share by Type (2021–2026)
Table 53. Global Dry Powder Inhaler Device Sales Market Share by Type (2027–2032)
Table 54. Global Dry Powder Inhaler Device Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Dry Powder Inhaler Device Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Dry Powder Inhaler Device Revenue Market Share by Type (2021–2026)
Table 57. Global Dry Powder Inhaler Device Revenue Market Share by Type (2027–2032)
Table 58. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2021–2026)
Table 59. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2027–2032)
Table 60. Global Dry Powder Inhaler Device Sales (K Units) by Application (2021–2026)
Table 61. Global Dry Powder Inhaler Device Sales (K Units) by Application (2027–2032)
Table 62. Global Dry Powder Inhaler Device Sales Market Share by Application (2021–2026)
Table 63. Global Dry Powder Inhaler Device Sales Market Share by Application (2027–2032)
Table 64. Global Dry Powder Inhaler Device Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Dry Powder Inhaler Device Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Dry Powder Inhaler Device Revenue Market Share by Application (2021–2026)
Table 67. Global Dry Powder Inhaler Device Revenue Market Share by Application (2027–2032)
Table 68. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2021–2026)
Table 69. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2027–2032)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. GlaxoSmithKline Dry Powder Inhaler Device Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. AstraZeneca Dry Powder Inhaler Device Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Boehringer Ingelheim Dry Powder Inhaler Device Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Chiesi Company Information
Table 86. Chiesi Description and Business Overview
Table 87. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Chiesi Dry Powder Inhaler Device Product
Table 89. Chiesi Recent Developments/Updates
Table 90. Cipla Company Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Cipla Dry Powder Inhaler Device Product
Table 94. Cipla Recent Developments/Updates
Table 95. 3M Company Information
Table 96. 3M Description and Business Overview
Table 97. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. 3M Dry Powder Inhaler Device Product
Table 99. 3M Recent Developments/Updates
Table 100. Hovione Company Information
Table 101. Hovione Description and Business Overview
Table 102. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Hovione Dry Powder Inhaler Device Product
Table 104. Hovione Recent Developments/Updates
Table 105. Mannkind Company Information
Table 106. Mannkind Description and Business Overview
Table 107. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Mannkind Dry Powder Inhaler Device Product
Table 109. Mannkind Recent Developments/Updates
Table 110. Mylan Company Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Mylan Dry Powder Inhaler Device Product
Table 114. Mylan Recent Developments/Updates
Table 115. Novartis Company Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. Novartis Dry Powder Inhaler Device Product
Table 119. Novartis Recent Developments/Updates
Table 120. Schering/Merck Company Information
Table 121. Schering/Merck Description and Business Overview
Table 122. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. Schering/Merck Dry Powder Inhaler Device Product
Table 124. Schering/Merck Recent Developments/Updates
Table 125. Teva Company Information
Table 126. Teva Description and Business Overview
Table 127. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Teva Dry Powder Inhaler Device Product
Table 129. Teva Recent Developments/Updates
Table 130. Vectura Company Information
Table 131. Vectura Description and Business Overview
Table 132. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. Vectura Dry Powder Inhaler Device Product
Table 134. Vectura Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Dry Powder Inhaler Device Distributors List
Table 138. Dry Powder Inhaler Device Customers List
Table 139. Dry Powder Inhaler Device Market Trends
Table 140. Dry Powder Inhaler Device Market Drivers
Table 141. Dry Powder Inhaler Device Market Challenges
Table 142. Dry Powder Inhaler Device Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dry Powder Inhaler Device
Figure 2. Global Dry Powder Inhaler Device Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Dry Powder Inhaler Device Market Share by Type: 2025 & 2032
Figure 4. Single Dose Product Picture
Figure 5. Multi Dose Product Picture
Figure 6. Global Dry Powder Inhaler Device Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Dry Powder Inhaler Device Market Share by Application: 2025 & 2032
Figure 8. Asthma
Figure 9. COPD
Figure 10. Others
Figure 11. Global Dry Powder Inhaler Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Dry Powder Inhaler Device Market Size (US$ Million), 2021–2032
Figure 13. Global Dry Powder Inhaler Device Sales (K Units), 2021–2032
Figure 14. Global Dry Powder Inhaler Device Average Price (USD/Unit), 2021–2032
Figure 15. Dry Powder Inhaler Device Report Years Considered
Figure 16. Dry Powder Inhaler Device Sales Share by Manufacturers in 2025
Figure 17. Global Dry Powder Inhaler Device Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Dry Powder Inhaler Device Players: Market Share by Revenue in Dry Powder Inhaler Device in 2025
Figure 19. Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
Figure 22. North America Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
Figure 23. U.S. Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
Figure 26. Europe Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
Figure 27. Germany Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Dry Powder Inhaler Device Revenue Market Share by Region (2021–2032)
Figure 34. China Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Taiwan Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Philippines Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
Figure 45. Latin America Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. U.A.E Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Dry Powder Inhaler Device by Type (2021–2032)
Figure 55. Global Revenue Market Share of Dry Powder Inhaler Device by Type (2021–2032)
Figure 56. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Dry Powder Inhaler Device by Application (2021–2032)
Figure 58. Global Revenue Market Share of Dry Powder Inhaler Device by Application (2021–2032)
Figure 59. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2021–2032)
Figure 60. Dry Powder Inhaler Device Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232